LongeVC | Latest News & Updates - Dec 25, 2024 Release

LongeVC's portfolio company Longenesis has partnered with Novartis Baltics on a pilot project to transform cardiovascular disease treatment and prevention in Latvia...


Brought to you by RivalSense - an AI tool for monitoring any company.

RivalSense tracks the most important product launches, fundraising news, partnerships, hiring activities, pricing changes, tech news, vendors, corporate filings, media mentions, and other developments of companies you're following 💡


LongeVC

🌎 longevc.com

LongeVC is a venture capital firm based in Lugano, Switzerland, founded in 2016. The company specializes in supporting early-stage biotech and longevity-focused founders, helping them gain industrial momentum, raise capital, and shape the future of the biotech industry. LongeVC aims to build a broad community of biotech innovators by funding companies in complementary sectors and facilitating collaboration among them.


LongeVC - Latest News and Updates

  • LongeVC's portfolio company Longenesis has partnered with Novartis Baltics on a pilot project to transform cardiovascular disease treatment and prevention in Latvia.
  • LongeVC participated in Proton Intelligence Inc.'s $6.95 million seed financing round for their Continuous Potassium Monitoring platform.
  • LongeVC has invested in Proton Intelligence, a company developing the first minimally invasive continuous potassium monitoring devices to improve management of chronic conditions.

Sign up to receive regular updates


If you liked the insights, consider following your own companies of interest. Receive weekly insights directly to your inbox using RivalSense.